Acute and chronic kidney function decline in patients receiving BRAF/MEK inhibitors for melanoma

Nephrol Dial Transplant. 2024 May 31;39(6):1040-1043. doi: 10.1093/ndt/gfae049.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acute Kidney Injury / chemically induced
  • Adult
  • Aged
  • Female
  • Glomerular Filtration Rate / drug effects
  • Humans
  • Kidney Function Tests
  • Male
  • Melanoma* / drug therapy
  • Middle Aged
  • Prognosis
  • Protein Kinase Inhibitors* / adverse effects
  • Protein Kinase Inhibitors* / therapeutic use
  • Proto-Oncogene Proteins B-raf* / antagonists & inhibitors
  • Renal Insufficiency, Chronic / complications
  • Renal Insufficiency, Chronic / drug therapy
  • Skin Neoplasms / drug therapy

Substances

  • Proto-Oncogene Proteins B-raf
  • Protein Kinase Inhibitors
  • BRAF protein, human

Grants and funding